Chapter 16 Drug treatment of endocrine disorders
INTRODUCTION
Endocrine disorders due to under- or overproduction of hormones are a major cause of morbidity and mortality. Certain endocrine disorders are a particular feature of life in the twenty-first century. The increasing levels of obesity on a worldwide scale, especially in the prosperous economies of the world, are associated with very high levels of diabetes. People in the UK with diabetes have broken the 2 million mark. Although great progress has been made in the treatment of both types of diabetes (improved oral hypoglycaemic agents, parenteral and inhaled insulin, diagnostic procedures and management), major concerns remain. Diabetes may be underdiagnosed by as much as 25% (Health and Social Care Information Centre 2005). Underdiagnosis, together with poor management by patients, greatly increases the risk of serious complications developing (cardiac, renal, ophthalmic, neuropathy). There is a major need for public education on diet and related matters to ensure that the risks of being unhealthy are well known and understood. Specialist health professionals can do much both in the field of prevention and the improvement of outcomes for patients.
HORMONAL REGULATION
Although each ductless gland (Fig. 16.1) produces a hormone with specific functions, there is an integrated relationship between the activities of the glands. If these relationships are disturbed by a disease process, the consequences can be far reaching.
Fig. 16.1 The endocrine glands.
(After Waugh A, Grant A 2001 Ross and Wilson anatomy and physiology in health and illness, 9th edn. Churchill Livingstone, Edinburgh. With permission of Elsevier.)
Chemoreceptors in the hypothalamus register the blood hormone level and react accordingly by either increasing or decreasing hormone production. If the blood hormone level is low, more hormone is secreted; if the blood hormone level is high, hormone production is reduced (negative feedback; see Fig. 16.2). Not all hormonal activities, however, follow this mechanism.
HYPOTHALAMUS AND PITUITARY GLAND
The hypothalamus forms the base of the brain (diencephalon). It is responsible for the coordination of nervous and endocrine systems and therefore many basic life functions such as cardiovascular, respiratory and alimentary functions, sexual behaviour and reproduction. It is connected to the pituitary gland, a small endocrine gland of great importance, by the hypophyseal stalk or infundibulum. The pituitary gland lies almost completely surrounded by bone in the base of the skull. It consists of three parts: the anterior lobe (adenohypophysis), the median eminence and the posterior lobe (neurohypophysis).
The anterior pituitary (see Fig. 16.3) synthesises and releases seven known trophic hormones. These are somatotrophin, which is involved in prepubertal body growth; prolactin, which stimulates the growth and secretory activity of the female breasts during pregnancy; melanocyte-stimulating hormone, which causes an increase in cutaneous pigmentation; adrenocorticotrophic hormone (ACTH), which governs the secretions of some of the hormones by the adrenal cortex; thyrotrophin (thyroid-stimulating hormone, TSH), which stimulates thyroid activity; follicle-stimulating hormone or human menopausal gonadotrophin, which stimulates growth of ovarian follicles and secretion of oestrogen in the female and spermatogenesis in the male; and luteinising hormone, which stimulates the production of progesterone in the corpus luteum of the follicle (female) and activates androgen secretion by the Leydig cells of the testis (male).
The posterior pituitary (see Fig. 16.4) hormones vasopressin (antidiuretic hormone, ADH) and oxytocin are produced in the hypothalamus and secreted (neurosecretion) directly into the bloodstream of the infundibulum and posterior lobe of the pituitary gland, from where they can be released into the body.
COMMON DISORDERS OF THE PITUITARY GLAND
HYPERSECRETION OF PITUITARY HORMONES
Hyperprolactinaemia may be due to a variety of causes, such as prolactinoma (prolactin-secreting tumour), trauma and drugs. Hyperprolactinaemia causes infertility in women and impotence in men. Treatment usually consists of a combination of surgery, radiotherapy and drug treatment depending on the size of the tumour.
MAIN DRUG GROUPS
HYPOTHALAMIC HORMONES AND ANTERIOR PITUITARY HORMONES
HYPOTHALAMIC HORMONES
ANTERIOR PITUITARY HORMONES
Corticotrophins
Use.
Tetracosactide and its slow-release form are used for diagnostic purposes to investigate adrenocortical insufficiency. Tetracosactide (250 micrograms) is given as an intramuscular or intravenous injection for a 30-min test. The depot preparation is used for a 5-h test (1 mg by intramuscular injection) in cases in which the 30-min test has been inconclusive or the functional reserve of the adrenal cortex is being tested. Owing to the variable and unpredictable therapeutic response, tetracosactide is no longer used as a therapeutic agent. Corticosteroids are preferred in the treatment of such inflammatory conditions as Crohn’s disease (see Chapter 11).
SOMATROPIN (SYNTHETIC HUMAN GROWTH HORMONE)
Administration and dose.
The dose is determined on an individual basis depending on the condition being treated.
POSTERIOR PITUITARY HORMONES
VASOPRESSIN (ANTIDIURETIC HORMONE)
Use.
Oesophageal varices
DOPAMINE RECEPTOR STIMULANTS (DOPAMINERGIC DRUGS)
Use.
The uses are outlined as follows:
THYROID GLAND
Production of hormones is stimulated by TSH, which is released from the anterior pituitary gland in response to hypothalamic thyrotrophin-releasing hormone. The production is regulated by negative feedback through circulating concentrations of free liothyronine (Fig. 16.5).
COMMON DISORDERS OF THE THYROID GLAND
HYPOTHYROIDISM (THYROID DEFICIENCY)
Hypothyroidism results from a reduced secretion by the thyroid gland, irrespective of the cause. The most common causes of primary hypothyroidism are thyroid failure following radioactive sodium iodine-131 therapy and surgical treatment, thyroid failure associated with Hashimoto’s thyroiditis or an autoimmune disease, and congenital thyroid failure (congenital hypothyroidism or cretinism). Hypothyroidism due to pituitary failure (secondary hypothyroidism) is much less common.
MAIN DRUG GROUPS
THYROID HORMONES
Administration and dose.
The dose can be monitored by the clinical response of the patient, but serum liothyronine and TSH levels should be measured at intervals. The correct dose of liothyronine is that which restores serum TSH concentration to normal.